Montecito Bank & Trust Purchases Shares of 40,000 Sabra Healthcare REIT, Inc. $SBRA

Montecito Bank & Trust acquired a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 40,000 shares of the real estate investment trust’s stock, valued at approximately $758,000.

Several other institutional investors have also recently modified their holdings of SBRA. Larson Financial Group LLC boosted its position in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 553 shares during the last quarter. Anchor Investment Management LLC increased its holdings in Sabra Healthcare REIT by 15.5% in the 3rd quarter. Anchor Investment Management LLC now owns 4,150 shares of the real estate investment trust’s stock worth $77,000 after buying an additional 556 shares during the period. Oppenheimer & Co. Inc. increased its holdings in Sabra Healthcare REIT by 1.7% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock worth $633,000 after buying an additional 581 shares during the period. Journey Strategic Wealth LLC raised its position in Sabra Healthcare REIT by 3.3% during the 3rd quarter. Journey Strategic Wealth LLC now owns 18,479 shares of the real estate investment trust’s stock worth $344,000 after buying an additional 595 shares during the last quarter. Finally, Natixis Advisors LLC raised its position in Sabra Healthcare REIT by 2.2% during the 3rd quarter. Natixis Advisors LLC now owns 27,664 shares of the real estate investment trust’s stock worth $516,000 after buying an additional 598 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Trading Up 0.2%

Sabra Healthcare REIT stock opened at $19.73 on Wednesday. The firm has a market cap of $4.97 billion, a PE ratio of 30.83, a P/E/G ratio of 1.57 and a beta of 0.64. Sabra Healthcare REIT, Inc. has a 12 month low of $15.75 and a 12 month high of $21.07. The stock’s 50 day simple moving average is $19.76 and its two-hundred day simple moving average is $19.06. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm had revenue of $201.35 million for the quarter, compared to analysts’ expectations of $201.97 million. During the same period last year, the firm earned $0.36 earnings per share. Sabra Healthcare REIT’s revenue for the quarter was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a yield of 6.1%. Sabra Healthcare REIT’s payout ratio is presently 187.50%.

Wall Street Analyst Weigh In

Several research firms have recently commented on SBRA. Wall Street Zen downgraded shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Scotiabank boosted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research report on Monday, March 2nd. Truist Financial upped their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Finally, Weiss Ratings raised Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Wednesday, March 18th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Sabra Healthcare REIT presently has an average rating of “Moderate Buy” and a consensus target price of $21.90.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.